Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 14/20 | 0.64 |
| ▸ | HTR2C | P28335 | 7/20 | 0.64 |
| ▸ | HTR2B | P41595 | 7/20 | 0.64 |
| ▸ | NSD2 | O96028 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26013318 | 0.90 | HTR2A (0.66) | HTR2AHTR2CHTR2BNSD2KMT2A | |
| SCHEMBL26013071 | 0.85 | HTR2A (0.67) | HTR2AHTR2CHTR2BNSD2KMT2A | |
| SCHEMBL26013317 | 0.85 | HTR2A (0.69) | HTR2AHTR2CHTR2BNSD2KMT2A | |
| SCHEMBL26013458 | 0.83 | HTR2A (0.69) | HTR2AHTR2CHTR2BNSD2KMT2A | |
| SCHEMBL26013390 | 0.82 | HTR2A (0.50) | HTR2AHTR2CHTR2BNSD2KMT2A | |
| SCHEMBL26013274 | 0.82 | HTR2A (0.71) | HTR2AHTR2CHTR2BNSD2KMT2A | |
| SCHEMBL26013139 | 0.81 | HTR2A (0.68) | HTR2AHTR2CHTR2BNSD2KMT2A | |
| SCHEMBL26012989 | 0.80 | HTR2A (0.67) | HTR2AHTR2CHTR2BNSD2KMT2A | |
| SCHEMBL26013683 | 0.80 | HTR2A (0.50) | HTR2AHTR2CNSD2KMT2ALMNA | |
| SCHEMBL25432406 | 0.79 | HTR2A (0.69) | HTR2AHTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023156450-A1 | THERAPEUTIC PHENETHYLAMINE COMPOSITIONS AND METHODS OF USE | CYBIN IRL LIMITED (IE) | 2023-08-24 | — | — | WO | disclosed |